Inspirata to Present and Exhibit at the Fall Symposium of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
128
Inspirata to Present and Exhibit at the Fall Symposium of Cancer Informatics for Cancer Centers (CI4CC) taking place at the Estancia Hotel & Spa in La Jolla, CA Oct. 23-25

La Jolla, CA, Oct. 23, 2017 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology workflow solution provider Inspirata ® , Inc. announced today that it will be exhibiting at the CI4CC Fall Symposium in La Jolla, CA Oct. 23-25. Inspirata’s Senior Vice President of Cancer Informatics, Dr. Trevor Heritage, will introduce Inspirata’s big data product vision during a presentation beginning at 11:30 on Monday, Oct. 23.

Dr. Heritage is responsible for leading the business strategy for Inspirata’s Cancer Information Data Trust (CIDT), which is a multi-institution, diagnostic image-anchored big data initiative. “The intent of the CIDT,” explains Dr. Heritage, “is to improve the diagnosis and treatment of cancer by providing stakeholders, such as clinicians, administrators, researchers, bio pharma scientists, patients and caregivers, with unique insights derived from longitudinal patient data ingested from multiple sources. We use our Natural Language Processing (NLP) engine, called CIDT.Structure ™ , to structure data and ensure it is fully searchable and mineable. The result is a repository that can be used to inform cancer treatment options, provide prognostic information, generate patient cohorts, assist with cancer reporting, quantify costs and quality of care, and identify population health trends.”

Inspirata’s end-to-end digital pathology workflow solution is a fully managed service that enables academic medical centers and cancer centers to assemble repositories of diagnostic images and clinical data to fuel their clinical, research and educational missions. A digital pathology cockpit, provided to each of the partner institutions’ pathologists as part of the workflow solution, accesses data from disparate health information systems, giving the pathologist a comprehensive view of a patient’s clinical history and current case details, including the whole slide images of tissue samples from the biopsied tumor. Having this information at their fingertips, pathologists can more rapidly arrive at an accurate diagnosis.

“The institutions we partner with gain a two-fold advantage,” says Inspirata CEO Satish Sanan. “First, they can move to a digital pathology workflow without the upfront investment needed for the technology or the resources to operationalize it. We make that initial investment for them. And, second, our partner institutions will have their own versions of the CIDT, giving them much easier access to cancer data that was previously dispersed in siloed systems or unavailable except through manual abstraction.”

About CI4CC

Cancer Informatics for Cancer Centers ( CI4CC ) is the nation’s premier professional society where academic and community medical centers, corporate professionals and many other subject matter experts in Biomedical Informatics, Clinical Trials, Precision Medicine, Healthcare-IT, Information Technology and Pharmaceutical industries come together to share their efforts. CI4CC is a nonprofit organization that provides a focused forum for clinical and academic research informatics scientists. The organization is led by executives from the Academic and Clinical Cancer Center community who volunteer their time.

About Inspirata, Inc.

Inspirata ® , Inc. offers the most comprehensive cancer diagnostics workflow solution available for precision diagnosis today. The solution, which employs a unique “solution-as-a-service” business and delivery model, accelerates anatomic and molecular pathology workflows and facilitates whole slide imaging and image analytics, prognostic and predictive assays, remote consultations and tumor boards. This comprehensive solution includes an Enterprise Service Bus (ESB) to help to solve interoperability issues and a Natural Language Processing Engine (NLP) for structuring data. Inspirata amalgamates this structured data into a central multi-institutional and multi-modal big data cancer repository for clinical, research and educational purposes. Its use will extend to physicians, patients, researchers and pharma among others. This comprehensive solution facilitates a modern precision diagnosis to build a strong foundation for precision medicine. For more information, please visit www.inspirata.com or contact info@inspirata.com .

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/Attachm...ddecc5711a

Marjorie Bulone Inspirata, Inc. 813-570-8905 mbulone@inspirata.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 5

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 4

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 2

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading

Top 5 Most Recently Viewed Articles

Ten Four Truck Insurance Welcomes Chris Johnstone on Board

Updated Category News Views 76

Exciting Leadership Move at Ten Four Truck Insurance Ten Four Truck Insurance, recognized as a premier provider of insurance solutions tailored specifically for the trucking industry, has recently elevated Chris Johnstone to the position of Director of Partnerships. This strategic appointment is set to enhance the company's collaborative efforts and broaden its partner...

Continue Reading
Innovative Screed Hook Design Enhances Concrete Pouring Process

Updated Category News Views 165

Revolutionizing the Concrete Construction Process In the bustling world of construction, efficiency is key. An inventive mind has recently introduced a specialized screed hook that promises to streamline the concrete pouring process significantly. This innovation is designed with a focus on ease of use, making it a practical addition for contractors and workers alike....

Continue Reading
SCR Expands Offerings Through Global Partnerships in Business Formation

Updated Category News Views 201

SCR Expands Offerings Through Global Partnerships In recent developments, SCR has made significant strides in enhancing its Offshore Company Formation services by forging international partnerships. These collaborations provide businesses and individuals with increased flexibility in establishing structures that can facilitate asset protection, succession planning, and...

Continue Reading
Response Pharmaceuticals Achieves Milestone in RDX-002 Study

Updated Category News Views 171

Response Pharmaceuticals Makes Significant Progress in Clinical Trial Response Pharmaceuticals, Inc., a company specializing in innovative weight management solutions, has announced a pivotal moment in its clinical trajectory. The firm has completed early enrollment in a Phase 2 clinical trial assessing the efficacy of its investigational drug candidate, RDX-002. This...

Continue Reading
Fifth Third Bancorp Faces Decline in Profit Due to Higher Provisions

Updated Category News Views 81

Fifth Third Bancorp Reports Lower Profits Amid Rising Provisions Fifth Third Bancorp (NASDAQ: FITB), a prominent financial institution, has reported a decrease in its profits for the third quarter, primarily influenced by heightened provisions for loan losses. The bank's recent financial disclosures have caught the attention of investors, culminating in a nearly 3% drop...

Continue Reading